SPRAVATO: Transforming Major Depressive Disorder Treatment
The treatment landscape for Major Depressive Disorder (MDD) is evolving rapidly, with SPRAVATO commercial success marking a significant milestone. SPRAVATO (esketamine) provides rapid symptom relief, particularly for patients with treatment-resistant depression, representing a breakthrough in modern depression therapy. As part of the latest depression treatment options and therapies 2025,...
0 Commentarii 0 Distribuiri 35 Views 0 previzualizare
Sponsor